All Stories

  1. Corrigendum to CERT1 mutations perturb human development by disrupting sphingolipid homeostasis
  2. De novo heterozygous variants in EHMT2 genocopy Kleefstra syndrome via loss of G9a methyltransferase activity
  3. CERT1 mutations perturb human development by disrupting sphingolipid homeostasis
  4. Differences in Expression of IQSEC2 Transcript Isoforms in Male and Female Cases with Loss of Function Variants and Neurodevelopmental Disorder
  5. A Multicountry Analysis of Prevalence and Mortality among Neonates and Children with Bladder Exstrophy
  6. Correction: Solving unsolved rare neurological diseases—a Solve-RD viewpoint
  7. Correction to: Solving patients with rare diseases through programmatic reanalysis of genome-phenome data
  8. Correction to: Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases
  9. Prevention of Neural Tube Defects in Europe: A Public Health Failure
  10. Solving patients with rare diseases through programmatic reanalysis of genome-phenome data
  11. Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases
  12. Solving unsolved rare neurological diseases—a Solve-RD viewpoint
  13. Prevalence and mortality in children with congenital diaphragmatic hernia: a multicountry study
  14. Survival of infants born with esophageal atresia among 24 international birth defects surveillance programs
  15. Smoking during pregnancy: changes and associated risk factors in Spain, 1980-2016
  16. Neonatal myocardial ischemia and calcifications. Report of a case of generalized arterial calcification of infancy
  17. Isquemia miocárdica neonatal y calcificaciones, presentación de un caso de calcificación arterial generalizada de la infancia
  18. De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defects
  19. A multi‐country study of prevalence and early childhood mortality among children with omphalocele
  20. Expanding the genotypic and phenotypic spectrum of severe serine biosynthesis disorders
  21. Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum
  22. Heterozygous pathogenic variants inGLI1are a common finding in isolated postaxial polydactyly A/B
  23. Analysis of Mortality among Neonates and Children with Spina Bifida: An International Registry‐Based Study, 2001‐2012
  24. Changes in Alcohol Intake During Pregnancy in Spain, 1980 to 2014
  25. Hypospadias Prevalence and Trends in International Birth Defect Surveillance Systems, 1980–2010
  26. Join World Birth Defects Day
  27. Tetralogy of Fallot in Spain: a nationwide registry-based mortality study across 36 years
  28. Value of sharing and networking among birth defects surveillance programs: an ICBDSR perspective
  29. SpainUDP: The Spanish Undiagnosed Rare Diseases Program
  30. A Nationwide Registry-Based Study on Mortality Due to Rare Congenital Anomalies
  31. SpainUDP: The Spanish Undiagnosed Rare Diseases Program
  32. Congenital Anomalies: Cluster Detection and Investigation
  33. Monitoring Huntington's Disease Mortality across a 30-Year Period: Geographic and Temporal Patterns
  34. Recurrent Mutations in the Basic Domain of TWIST2 Cause Ablepharon Macrostomia and Barber-Say Syndromes
  35. Deletion 1q43-44 in a patient with clinical diagnosis of Warburg-Micro syndrome
  36. Delineation of the clinically recognizable 17q22 contiguous gene deletion syndrome in a patient carrying the smallest microdeletion known to date
  37. European Recommendations for Primary Prevention of Congenital Anomalies: A Joined Effort of EUROCAT and EUROPLAN Projects to Facilitate Inclusion of This Topic in the National Rare Disease Plans
  38. Interstitial deletion 14q22.3-q23.2: Genotype-phenotype correlation
  39. Haploinsufficiency ofBMP4gene may be the underlying cause of Frías syndrome
  40. Patient with disorganization syndrome: Surgical procedures, Pathology, and potential causes
  41. Defectos congénitos en recién nacidos y fetos procedentes de interrupción del embarazo tras diagnóstico prenatal en el período 1982-2009
  42. A 2.84 Mb deletion at 21q22.11 in a patient clinically diagnosed with marden-walker syndrome
  43. Cyclopia: An epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research
  44. Amelia: A multi-center descriptive epidemiologic study in a large dataset from the International Clearinghouse for Birth Defects Surveillance and Research, and overview of the literature
  45. Cloacal exstrophy: An epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research
  46. Bladder exstrophy: An epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research, and an overview of the literature
  47. Phocomelia: A worldwide descriptive epidemiologic study in a large series of cases from the International Clearinghouse for Birth Defects Surveillance and Research, and overview of the literature
  48. Pautas de prevención de defectos congénitos con especial referencia a los niveles primario y secundario. Guías de actuación preventiva desde la atención primaria
  49. Characterization of a 8q21.11 Microdeletion Syndrome Associated with Intellectual Disability and a Recognizable Phenotype
  50. Thanatophoric dysplasia type II with encephalocele and semilobar holoprosencephaly: Insights into its pathogenesis
  51. Ejemplos clínicos de alteraciones crípticas del ADN, y guías para sospechar que un niño pueda tener alguna alteración críptica o molecular
  52. Frecuencias de defectos congénitos al nacimiento en España y su comportamiento temporal y por comunidades autónomas. Causas de las variaciones de las frecuencias
  53. Prevention, Diagnosis and Services
  54. Review of the recently defined molecular mechanisms underlying thanatophoric dysplasia and their potential therapeutic implications for achondroplasia
  55. Epidemiological and clinical analysis of a consecutive series of conjoined twins in Spain
  56. Epidemiology of acephalus/acardius monozygotic twins: New insights into an epigenetic causal hypothesis
  57. Presentación de un caso con síndrome de Alström: aspectos clínicos, moleculares y guías diagnósticas y anticipatorias
  58. Preferential Associations Between Oral Clefts and Other Major Congenital Anomalies
  59. Análisis de las frecuencias de todas las combinaciones genotípicas de 4 polimorfismos de genes implicados en el ciclo del folato en la población española
  60. Epidemiological association between isolated skin marks in newborn infants and single umbilical artery (SUA). Does it have biological plausibility?
  61. Adecuación de las dosis de ácido fólico en la prevención de defectos congénitos
  62. Pilot Study of Socioeconomic Class, Nutrition and Birth Defects in Spain
  63. Evolución secular y por comunidades autónomas de la frecuencia de síndrome de Down al nacimiento en hijos de madres jóvenes
  64. Síndrome de Dyggve-Melchior-Clausen: presentación de un caso con una mutación de posible origen español
  65. Gastroschisis and associated defects: An international study
  66. Does single umbilical artery (SUA) predict any type of congenital defect? Clinical–epidemiological analysis of a large consecutive series of malformed infants
  67. Características de los neonatos con y sin arteria umbilical única. Análisis de dos series consecutivas de recién nacidos con y sin defectos congénitos
  68. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study
  69. Análisis comparativo de las frecuencias de ciertos defectos congénitos y su evolución secular en 11 comunidades autónomas
  70. The incidence of gastroschisis: Is also increasing in Spain, particularly among babies of young mothers
  71. Maternal polymorphisms 677C-T and 1298A-C of MTHFR, and 66A-G MTRR genes: Is there any relationship between polymorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down syndrome?
  72. Respuesta de los autores
  73. Posibles sesgos metodológicos en estudios de prevalencia del hábito de fumar durante el embarazo en España
  74. Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes
  75. New findings in craniofacial dyssynostosis
  76. Evolución secular y por autonomías de la frecuencia de tratamientos de fertilidad, partos múltiples y cesáreas en España
  77. Consumo de tabaco durante el embarazo en España: análisis por años, comunidades autónomas y características maternas
  78. Growth deficiency, facial anomalies, and brachydactyly (Frías syndrome): A second family
  79. Craniofacial dyssynostosis: Description of the first four Spanish cases and review
  80. Sensorineural deafness, abnormal genitalia, synostosis of metacarpals and metatarsals 4 and 5, and mental retardation: Description of a second patient and exclusion ofHOXD13
  81. MTHFR677C-T polymorphism is not excluded as maternal risk for Down syndrome among Turkish women
  82. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: A case-control study
  83. Frecuencia de la mutación 677C-T del gen de la metilentetrahidrofolato reductasa en una muestra de 652 recién nacidos de toda España
  84. Secular decreasing trend of the frequency of hypospadias among newborn male infants in Spain
  85. Frecuencia de la mutación 677C-T del gen de la metilentetrahidrofolato reductasa en una muestra de 652 recién nacidos de toda España
  86. Análisis de la situación en España sobre el consumo de ácido fólico/folinato cálcico para la prevención de defectos congénitos
  87. Frequency of neural tube defects and down syndrome in the same sibship: Analysis of the Spanish ongoing case-control study
  88. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide
  89. Evolución temporal y por comunidades autónomas del consumo de diferentes cantidades de alcohol durante el embarazo
  90. Análisis de la situación en España sobre el consumo de ácido fólico/folinato cálcico para la prevención de defectos congénitos
  91. Evolución temporal y por comunidades autónomas del consumo de diferentes cantidades de alcohol durante el embarazo
  92. Diagnóstico prenatal temprano del síndrome de regresión caudal asociado con la diabetes mellitus
  93. Incidence of Smith‐Lemli‐Opitz syndrome in Ontario, Canada
  94. Nowadays it is preceptive to perform chromosomal studies with high resolution G‐bands and FISH techniques when necessary
  95. ‘The VACTERL association: lessons from the Sonic hedgehog pathway’
  96. Epidemiological evidence that maternal diabetes does not appear to increase the risk for Down syndrome
  97. Reply to the research letter by Bohring-“OEIS complex, VATER, and the ongoing difficulties in terminology and delineation”
  98. Periconceptional Exposure to Contraceptive Pills and Risk for Down Syndrome
  99. Exstrophy of the cloaca and exstrophy of the bladder: Two different expressions of a primary developmental field defect
  100. High maternal fever during gestation and severe congenital limb disruptions
  101. It is necessary to perform high-resolution band chromosomes in any child with malformations, before making a diagnosis or establishing a possible relationship with any risk factor
  102. On the symmetry of limb deficiencies among childrenwith multiple congenital anomalies
  103. Body stalk defects, body wall defects, amniotic bands with and without body wall defects, and gastroschisis: Comparative epidemiology
  104. Spina bifida and parental occupation: Results from three malformation monitoring programs in Europe
  105. Pathogenetic classification of a series of 27,145 consecutive infants with congenital defects
  106. Pathogenetic classification of a series of 27,145 consecutive infants with congenital defects
  107. Isolated small intestinal atresias in Latin America and Spain: Epidemiological analysis
  108. Limb deficiencies in infants with trisomy 13
  109. Anal atresia, vertebral, genital, and urinary tract anomalies: A primary polytopic developmental field defect identified through an epidemiological analysis of associations
  110. Maternal and Fetal Factors Related to Abnormal Amniotic Fluid
  111. Analysis of deformations in 26,810 consecutive infants with congenital defects
  112. Smoking during pregnancy and Poland sequence: Results of a population-based registry and a case-control registry
  113. Smoking during pregnancy and Poland sequence: Results of a population‐based registry and a case‐control registry
  114. To the editor:
  115. To the Editor:
  116. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers
  117. Congenital Anomalies in the Offspring of Mothers With a Bicornuate Uterus
  118. Prenatal exposure to penicillamine and oral clefts: Case report
  119. Cyclopia and sirenomelia in a liveborn infant.
  120. Congenital eye malformations: Clinical‐epidemiological analysis of 1,124,654 consecutive births in Spain
  121. Congenital eye malformations: Clinical-epidemiological analysis of 1,124,654 consecutive births in Spain
  122. Prenatal exposure to sex hormones: A case‐control study
  123. Prenatal exposure to sex hormones: A case‐control study
  124. Amelia: Analysis of its epidemiological and clinical characteristics
  125. Amelia: Analysis of its epidemiological and clinical characteristics
  126. Severe limb deficiencies, vertebral hypersegmentation, and mirror polydactyly: Two additional cases that expand the phenotype to a more generalized effect on blastogenesis
  127. Major congenital malformations in Down syndrome
  128. Correlation between drug exposure and major malformations
  129. Epidemiological analysis of the schisis association in the Spanish registry of congenital malformations
  130. Epidemiological analysis of the schisis association in the Spanish registry of congenital malformations
  131. Correlation between drug exposure and major malformations
  132. Epidemiological analysis of multi‐site closure failure of neural tube in humans
  133. Epidemiological analysis of multi-site closure failure of neural tube in humans
  134. Epidemiological analysis of rare polydactylies
  135. Erratum
  136. Clinical/epidemiological analysis of congenital anomalies associated with diaphragmatic hernia
  137. Clinical/epidemiological analysis of congenital anomalies associated with diaphragmatic hernia
  138. Primary midline developmental field. II. Clinical/epidemiological analysis of alteration of laterality (normal body symmetry and asymmetry)
  139. Holoprosencephaly associated with caudal dysgenesis: A clinical-epidemiological analysis
  140. Severe spondylocostal dysostosis associated with other congenital anomalies: A clinical/epidemiologic analysis and description of ten cases from the Spanish registry
  141. Chromosome 4p16 and osteochondroplasias
  142. Sclerocornea, hypertelorism, syndactyly, and ambiguous genitalia
  143. Short rib-polydactyly syndrome and pericentric inversion of chromosome 4
  144. Lethal short rib-polydactyly syndromes: further evidence for their overlapping in a continuous spectrum.
  145. Short rib-polydactyly syndrome (SRPS) with anencephaly and other central nervous system anomalies: A new type of SRPS or a more severe expression of a known SRPS entity?
  146. Bilateral anophthalmia, esophageal atresia, and right cryptorchidism: A new entity?
  147. Preaxial polydactyly of feet in infants of diabetic mothers: Epidemiological test of a clinical hypothesis
  148. Value of clinical analysis in epidemiological research: The Spanish registry experience
  149. Epidemiological aspects of Mendelian syndromes in a spanish population sample: I. Autosomal dominant malformation syndromes
  150. Epidemiological aspects of Mendelian syndromes in a Spanish population sample: II. Autosomal recessive malformation syndromes